Financial Shenanigans

The Forensic Verdict

Wix is a faithful but aggressively-presented set of books. Reported revenue, receivables and cash collections reconcile cleanly through a ratable, collect-up-front SaaS model with no signs of channel-stuffing, bill-and-hold or related-party revenue inflation. The forensic risk is not in revenue recognition — it sits in the distance between GAAP profit and management's preferred non-GAAP narrative, the acquisition-accrual mechanics that lifted 2025 operating cash flow, and a handful of governance items (founder-family related-party deal, dropped subscription disclosure, deeply negative equity funded by serial convertibles) that warrant ongoing diligence. The single data point that would most change this grade in either direction is the FY2026 reconciliation of contingent-consideration accruals tied to the Base44 acquisition — if those convert to cash or release through the income statement, both CFO and GAAP earnings will move materially.

Grade: Watch (38/100). Two concerns dominate: (1) FY2025 non-GAAP net income of $441.6M sits 8.7x GAAP net income of $50.6M, driven mostly by add-backs of share-based compensation ($237M) and Base44 acquisition-related charges; (2) FY2025 operating cash flow of $582.9M was lifted by a $204M swing in accrued expenses and other liabilities, most of which appears tied to Base44 contingent-consideration accruals that pass through R&D and back into CFO as a working-capital source. Offsetting these are clean tests across revenue recognition, receivables, soft-asset growth and auditor continuity. A material weakness, restatement, regulatory inquiry or auditor change would push the grade to Elevated/High; another year of clean GAAP earnings, lower SBC intensity and a transparent contingent-consideration disclosure would push it toward Clean.

Shenanigans Scorecard (13-category coverage)

Breeding Ground

Structural conditions are mixed-but-mostly-benign. Wix has independent board oversight, a long-tenured audit chair, an unchanged Big Four auditor (Kost Forer Gabbay & Kasierer / EY Israel) and no history of restatement, qualification, late filing or material weakness. The pressure points are founder dominance, family relationships at the top, and the lighter disclosure regime that comes with Foreign Private Issuer status.

The Dazl Technologies transaction — disclosed under Item 7.B Related Party Transactions — is the single item that would benefit from more public detail. Wix transferred unspecified IP and roughly 30 employees into a newly-formed subsidiary, retained a 30% stake at a $9.25 million round size, and the CEO's brother is the co-founder. The transaction is small relative to the balance sheet and the audit committee signed off on arm's-length terms, but the structure (insiders, IP, talent, equity carve-out) is a textbook breeding-ground signal worth tracking over time.

Earnings Quality

Reported earnings are economically real but lumpy and heavily flattered by below-the-line items. Revenue is recognized ratably from upfront subscription cash collections, refunds are deferred for 14 days, and the receivables footprint is microscopic (7.6 days sales). The income-statement risk lies elsewhere: a $51M tax-benefit boost that doubled 2025 net income, a $114M Base44 acquisition charge that landed in R&D, and a non-GAAP-versus-GAAP gap that has been wide for years.

Revenue is collected before it is recognized

Receivables fell 7% in FY2025 while revenue grew 13%. DSO compressed back to roughly 8 days, well below the SaaS-peer range. No sign of revenue being pulled forward through extended terms, contract-asset build-up or non-arm's-length channel sales. Deferred-revenue balances grew to $854M (short + long-term), the natural fingerprint of a subscription business collecting cash up front. This is the cleanest single test in the report.

GAAP net income is materially boosted by a one-time tax benefit

The $51 million income-tax benefit in FY2025 came from releasing a deferred-tax-asset valuation allowance now that Wix is sustainably profitable on a cumulative GAAP basis (per MD&A). Stripping it out, pre-tax income was $1.1 million. The benefit is real accounting, but it is non-recurring, and it accounts for roughly the entire reported FY2025 net income.

Below-the-line acquisition charges are doing the heavy lifting

Operating margin collapsed from 5.7% in FY2024 to 0.1% in FY2025, despite revenue growing 13%. The compression is driven primarily by $114M of Base44 acquisition-related charges hitting R&D (which grew 30% YoY to $645M, or 32.4% of revenue) and a ~$74M Base44 marketing step-up in S&M. Net margin rose from operating margin because of the non-cash tax benefit. Management's narrative — that the cost is a "necessary investment" — is plausible; the forensic point is that current GAAP profitability would not exist absent the tax benefit, and FY2026 R&D commentary signals further acquisition earn-out charges.

Cash Flow Quality

Operating cash flow looks great. The mechanism behind it is what matters. FY2025 CFO of $582.9 million is the headline; on inspection, more than half of it is non-cash add-backs and working-capital movements tied to acquisition accounting and growth-driven deferred revenue.

CFO has run several multiples of GAAP net income for years. In a profitable SaaS business with heavy SBC and ratable revenue, that is structural, not suspicious — but it means CFO is not a clean proxy for owner earnings.

What is actually inside FY2025 CFO

Two items move CFO more than GAAP net income does. Share-based compensation is the largest single add-back at $237M, or 11.9% of revenue. The increase in accrued expenses and other current liabilities swung +$204M in FY2025 versus +$3M in FY2024, and the FY2025 balance sheet shows "Other long-term liabilities" jumping from $16M to $200M — most of which appears tied to Base44 contingent-consideration. That liability is the cash mirror of the $114M acquisition-related R&D expense; the expense lowers GAAP earnings without consuming cash, and the accrued liability lifts CFO.

The forensic implication is not that the accounting is wrong. It is that a meaningful portion of FY2025 CFO is mechanical, not operating. Stripping just SBC ($237M) from FCF takes the $574M headline to $337M. Stripping SBC and treating the $204M accrued-liability swing as one-time takes it closer to $130M — about 6.5% of revenue, not 28.8%.

Deferred revenue is the recurring lever

Deferred revenue rose $76M short-term and $28M long-term in FY2025 — a $104M CFO source. This is a genuine cash advance from subscribers, recurring as long as billings continue to grow faster than recognition. If subscription growth flattens, this lever flips and CFO converges toward net income. The Q4'25 disclosure that premium subscriptions fell 1% YoY is the early signal to watch.

SBC dwarfs every other non-cash item

SBC intensity has fallen from 17% to 12% as revenue scaled — a positive trend — but SBC is still the single largest non-cash expense and is added back to every non-GAAP measure. Treat the full $237M as a real economic cost; the company is renting capital from employees and paying for it in dilution that is then partly offset by treasury buybacks.

Metric Hygiene

Wix uses an unusually long menu of non-GAAP and operating metrics — bookings, ARR (creative + business), free cash flow, "free cash flow as adjusted," constant-currency revenue, NRR, GPV, "Partners revenue," "Transaction revenue" and cohort bookings. The two issues are (1) the persistent and large GAAP-versus-non-GAAP gap and (2) the quiet retirement of the premium-subscriptions count just as the number turned negative.

The GAAP / non-GAAP gap

The FY2025 reconciliation adds back SBC ($237M), acquisition-related expenses (transaction costs + retention payments tied to Base44 / Hour One), amortization of intangibles, sales-tax accruals, "other G&A income," debt-issuance amortization, and non-operating FX. The Q4 picture is even more stark — GAAP loss of $40M flipped to non-GAAP profit of $111M, a $151M reconciliation swing in a single quarter. Non-GAAP earnings should be treated as the ceiling of true profitability, not the base case; GAAP earnings excluding the one-time tax benefit are closer to the floor.

Stopped disclosure: premium subscriptions

Management said directly in the FY2025 20-F: "Given our continued transition toward higher long-term value users, we believe total number of premium subscriptions at year end is no longer the best measure to reflect the underlying strength of our business. While we may provide updates at certain points in the future, we will no longer provide our total number of premium subscriptions on a regular basis." The argument has commercial merit. The forensic flag is the timing — disclosure is being retired in the same year the number turned negative.

Capital-return optics are large but explainable

Wix rolled its 2025 convertibles into 2030 0.00% converts ($1.15B), repurchased $575M of stock, and finished the year with shareholders' deficit of -$366M. In March 2026 management announced a $1.6B Dutch tender (executed April 3, 2026 at $92) and raised ~$250M of new equity from Durable Capital Partners (externally confirmed at $250M per Globes, March 4 2026; the $260M figure carried by some prior drafts is not externally confirmed). The "borrow + buy back + then sell new equity" optics require attention but are not, on this evidence, a forensic problem — they are an aggressive but disclosed capital-allocation choice supported by genuine cash generation. The risk to monitor is leverage if FCF compresses while the buyback program runs.

What to Underwrite Next

The five items below are the diligence punch list for the next two quarterly windows. None rises to "thesis breaker" today, but each is the data point that would resolve the Watch grade in either direction.